Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters

Study Title
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
Teva Identifier
DSG-HSP-201
ClinicalTrials.gov Identifier
NCT01388491
Study Status
Completed
Trial Condition(s)
Hemostasis | Oral Contraceptive
Interventions
Drug: desogestrel/ethinyl estradiol and ethinyl estradiol | Drug: desogestrel/ethinyl estradiol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female
Age Range
18 Years to 40 Years
Trial Duration
10/01/2011 - 09/01/2012
Phase
Phase 2

Study Type

Interventional